Quantcast
Last updated on April 16, 2014 at 8:06 EDT

Latest Non-steroidal anti-inflammatory drugs Stories

2014-01-17 08:22:56

- Mallinckrodt to Launch PENNSAID 2% in the U.S. in Q1 2014 - MISSISSAUGA, ON, Jan. 17, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology today announced that the U.S. Food and Drug Administration (FDA) has approved Mallinckrodt's New Drug Application for PENNSAID(®) (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a follow-on product to...

2014-01-16 20:22:22

F.A.S.T. Pain Relief is a new single-dose OTC liquid shot that recently launched in Seattle, WA SEATTLE, Jan. 16, 2014 /PRNewswire/ -- Consumers concerned with recent FDA warnings about risky Acetaminophen doses may be reviewing their options, and First Aid Shot Therapy® (F.A.S.T.) Liquid Pain Relief should be on their radar. This new product contains choline salicylate, which can get into the bloodstream up to five times faster than aspirin*[i], helping deliver relief from pain...

2014-01-10 23:03:17

A daily low-dose aspirin can help stave off heart attacks and certain clot-caused strokes. But fewer than half of the people who could benefit from this drug take it, while many others take it when they shouldn't. Boston, MA (PRWEB) January 10, 2014 Aspirin is often hailed as a wonder drug, thanks to its ability to help stave off heart attacks and clot-caused strokes. But fewer than half of people who could benefit from a daily low-dose aspirin take it, while many others take it when...

2014-01-08 12:29:06

Slomski's addition and Cleveland Clinic study adds to FPR Specialty Pharmacy's market expansion plans VICTOR, N.Y., Jan. 8, 2014 /PRNewswire/ -- FPR Specialty Pharmacy, developer of Focused Pain Relief--custom transdermal creams for pain and inflammation--today announced the appointment of Douglas B. Slomski to the position of Vice President of Sales and Marketing. Effective immediately, Slomski will be responsible for expanding the company's presence in existing markets, as well as...

2013-12-31 23:01:06

Virginia Hearing Consultants' Audiologists wish to inform the public about the fact that a large number of commonly used medications are oxotoxic and may cause hearing problems. Norfolk, VA (PRWEB) December 31, 2013 Both doctor-prescribed and over-the-counter (OTC) drugs can be ototoxic. The American Speech-Language-Hearing Association (ASLHA) advises that there are more than 200 medications known to be ototoxic, many of which are commonly used. To draw attention to this issue and...

2013-12-22 16:20:22

DUBLIN, Dec. 22, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wj54rz/ophthalmic#summary) has announced the addition of the "Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Ophthalmic pharmaceutical drugs is a uniquely competitive market kept perennially vibrant by refining technological changes in drug formulations and efficacy. Conventional drug...

2013-12-17 16:23:37

Depomed to host investor conference call today at 5:00 p.m. EST, 2:00 p.m. PST NEWARK, Calif., Dec. 17, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it has acquired the United States rights to CAMBIA® (diclofenac potassium for oral solution) from Nautilus Neurosciences for $48.7 million. In addition, Depomed may pay Nautilus up to an additional $5 million based on the achievement of certain annual net sales milestones. CAMBIA is a non-steroidal anti-inflammatory...

2013-12-11 08:31:59

F.A.S.T. Pain Relief's Active Ingredient May Be Absorbed Into the Blood Stream Up to Five Times Faster than Aspirin*1; Product Debuts in Seattle with Bartell Drugs, Amazon.com and Haggen/Top Foods SEATTLE, Dec. 11, 2013 /PRNewswire/ -- When the former Head of Gastroenterology at Stanford University and now current Professor of Medicine at John Hopkins School of Medicine teamed up with a former Coca-Cola executive to design a new over-the-counter (OTC) pain relief medication, the...

2013-11-29 23:00:52

Essential Wholesale is releasing five new ingredients for personal care. New offerings include Salicylic Acid, Colloidal sulfur, Caffeine, Calcium carbonate and refined Argan oil. Portland, Oregon (PRWEB) November 29, 2013 Essential Wholesale is releasing five new ingredients for personal care. New offerings include Salicylic Acid, Colloidal sulfur, Caffeine, Calcium carbonate and refined Argan oil. “Clients have been requesting these ingredients for some time,” says Laura Badcock,...

2013-11-21 08:28:00

MADISON, Tenn., Nov. 21, 2013 /PRNewswire/ -- Older dogs and active dogs feel aches and pains after a long day just like the rest of us. Until recently, a proven alternative to NSAID pain relievers for dogs has been sorely lacking from the market, but this has changed with the introduction of CanineActiv® (http://canineactiv.com). With a proprietary blend of ingredients specially chosen to restore and rejuvenate damaged tissue in dogs, this breakthrough treatment is sure to have...